RecallDepth
Class III Terminated

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.

This recall has been terminated (originally issued January 25, 2017).

Company
Teva Pharmaceuticals Usa
Recall Initiated
December 1, 2016
Posted
January 25, 2017
Recall Number
D-0431-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6,800 cartons
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot # 34027040A; Exp 10/17

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls